Dose-dependent effects of glucocorticoids on pulmonary vascular development in a murine model of hyperoxic lung injury
Autor: | Kathryn N. Farrow, Marta Perez, Herminio J. Cardona, Keng Jin Lee, Joann M. Taylor, Kamila Wisniewska |
---|---|
Rok vydání: | 2016 |
Předmět: |
medicine.medical_specialty
Pathology Hydrocortisone Hypertension Pulmonary Hyperoxia Pulmonary Artery 030204 cardiovascular system & hematology Lung injury Article Muscle hypertrophy Mice 03 medical and health sciences 0302 clinical medicine Right ventricular hypertrophy 030225 pediatrics medicine.artery Internal medicine medicine Animals Humans Glucocorticoids Lung Cyclic Nucleotide Phosphodiesterases Type 5 Dose-Response Relationship Drug Hypertrophy Right Ventricular business.industry Lung Injury respiratory system medicine.disease Pulmonary hypertension Elastin respiratory tract diseases 3. Good health Mice Inbred C57BL Pulmonary Alveoli Endocrinology medicine.anatomical_structure cGMP-specific phosphodiesterase type 5 Pediatrics Perinatology and Child Health Pulmonary artery medicine.symptom business Signal Transduction |
Zdroj: | Pediatric research |
ISSN: | 1530-0447 0031-3998 |
DOI: | 10.1038/pr.2016.1 |
Popis: | BACKGROUND Exposure of neonatal mice to hyperoxia results in pulmonary vascular remodeling and aberrant phosphodiesterase-5 (PDE5) signaling. Although glucocorticoids are frequently utilized in the NICU, little is known about their effects on the developing pulmonary vasculature and on PDE5. We sought to determine the effects of hydrocortisone (HC) on pulmonary vascular development and on PDE5 in a neonatal mouse model of hyperoxic lung injury. METHODS C57BL/6 mice were placed in 21% O2 or 75% O2 within 24h of birth and received HC (1, 5, or 10 mg/kg subcutaneously every other day) or vehicle. At 14d, right ventricular hypertrophy (RVH), medial wall thickness (MWT), lung morphometry, and pulmonary artery (PA) PDE5 activity were assessed. PDE5 activity was measured in isolated pulmonary artery smooth muscle cells (PASMC) exposed to 21% or 95% O2 ± 100nM HC for 24h. RESULTS Hyperoxia resulted in alveolar simplification, RVH, increased MWT, and increased PA PDE5 activity. HC decreased hyperoxia-induced RVH and attenuated MWT. HC had dose-dependent effects on alveolar simplification. HC decreased hyperoxia-induced PDE5 activity in vivo and in vitro. CONCLUSIONS HC decreases hyperoxia-induced pulmonary vascular remodeling and attenuates PDE5 activity. These findings suggest that HC may protect against hyperoxic injury in the developing pulmonary vasculature. |
Databáze: | OpenAIRE |
Externí odkaz: |